Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Equity (2020 - 2025)

Pulmonx (LUNG) has disclosed Return on Equity for 6 consecutive years, with 0.78% as the latest value for Q2 2025.

  • On a quarterly basis, Return on Equity fell 23.0% to 0.78% in Q2 2025 year-over-year; TTM through Jun 2025 was 0.78%, a 23.0% decrease, with the full-year FY2024 number at 0.55%, down 11.0% from a year prior.
  • Return on Equity was 0.78% for Q2 2025 at Pulmonx, down from 0.7% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.17% in Q1 2021 to a low of 0.78% in Q2 2025.
  • A 5-year average of 0.42% and a median of 0.38% in 2023 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: tumbled -31bps in 2021, then decreased -11bps in 2022.
  • Pulmonx's Return on Equity stood at 0.25% in 2021, then plummeted by -51bps to 0.37% in 2022, then decreased by -17bps to 0.44% in 2023, then tumbled by -44bps to 0.63% in 2024, then dropped by -24bps to 0.78% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Equity are 0.78% (Q2 2025), 0.7% (Q1 2025), and 0.63% (Q4 2024).